The study methodologies used to examine Hospital Acquired Infections (HAI) Diagnostics Market for the forecast period, 2020 - 2027 further classifies the industry by type, geography, end-use and end-user to add more precision and bring to light factors responsible for augmenting business development.

New York, NY -- (SBWire) -- 04/19/2021 --The global Hospital Acquired Infections (HAI) Diagnostics market is forecast to reach USD 5.68 Billion by 2027, according to a new report by Reports and Data. The market is growing due to the rise in the number of HAIs or hospital-acquired infections, and growth in the incidence of contagious virus-related diseases. The technological advancement and increasing awareness among the public have led to an increase in the number of surgical operations, which in turn is augmenting the demand for the industry.

Immediate diagnosis of infectious disease is the present need of the time due to evolving pathogens and increasing the occurrence rate of hospital-acquired infections. The government of various nations has been emphasizing on rapid diagnosis of infectious disease as a strategic priority like in the U.S. The global COVID-19 pandemic is another mentionable crucial factor that is boosting the demand for laboratory-based molecular testing capacity and reagents.

However, one of the mentionable challenges for the growth of the market players amidst this epidemic is supply chain management. As an instance, in China, when the pandemic reached the zenith, the transportation was to a halt that resulted in breaking the supply chain. The main reason for such disruption is not because companies are not manufacturing, but it was because the mobility of comments from one part of the nation to another was becoming a challenge. Thus, such disruption in the supply chain may hinder the growth of the market.

Key participants include Abbott Laboratories, Roche AG, bioMérieux, Alere, Inc., Becton Dickenson, Siemens Healthcare, Thermo Fisher Scientific, Cepheid Inc., Qiagen, and Seegene, Inc., among others.

To Get Sample Copy of Report visit: https://www.reportsanddata.com/sample-enquiry-form/3478

The Covid-19 Impact

One of the major impacts of COVID-19 on the market has been elevated demand for point-of-care immunodiagnostic tests. The development of these easy-to-use and rapid devices to support testing outside of laboratory settings has been a response of diagnostic test manufacturers to shortages of laboratory-based molecular testing capacity. These test kits are developed by manufacturers based either on detection, in serum or blood of antibodies caused due to the infection or identification of proteins from the coronavirus in respiratory samples. WHO supports the use of these point-of-care immunodiagnostic tests in research settings.

For the purpose of this report, Reports and Data have segmented into the global Hospital Acquired Infections (HAI) Diagnostics market on the basis of the product, test type, application, infection type, end-user, and region:

Product Outlook (Revenue, USD Billion; 2017-2027)

Consumables
Instruments and Reagents

Test Type Outlook (Revenue, USD Billion; 2017-2027)

Urinalysis
Molecular Diagnostic
Immunoassay

Application Outlook (Revenue, USD Billion; 2017-2027)

Drug Resistance Testing
Disease Testing

Infection Type Outlook (Revenue, USD Billion; 2017-2027)

Bloodstream Infections
Gastrointestinal Infections
Hospital-Acquired Pneumonia
Surgical Site Infections
Urinary Tract Infections (UTI)
Others

End Users Outlook (Revenue, USD Billion; 2017-2027)

Clinics
Hospitals
Ambulatory Surgery Centers (ASC)
Others

Regional Outlook (Revenue, USD Billion; 2017-2027)

North America
Europe
Asia Pacific
Latin America
MEA

To get a Discount on the Hospital Acquired Infections (HAI) Diagnostics Market Report, Click @ https://www.reportsanddata.com/discount-enquiry-form/3478

Further key findings from the report suggest

Urinalysis testing procedure is used to detect as well as manage a various range of disorders, such as kidney diseases, urinary tract infections, and diabetes. It involves checking the concentration, appearance, and content of the urine. It may result in illness or diseases.

Gastrointestinal infections is among the most commonly encountered infections in primary care. They are not always severe and can often be resolved quickly. They can be serious inpatient populations and healthcare settings.

Among applications, disease testing in HAI diagnostic is anticipated to witness a higher growth rate during the forecast period. Due to the advancement in technology in the healthcare sector, many modern diagnostic instruments and techniques have made the process more accurate.

North America held the largest market share throughout the forecast period. The region is anticipated to witness several growth opportunities leading to the increase in the level of awareness among consumers owing to the presence of a large number of educational institutes, hospitals, corporate buildings, and also rise in the self-hygiene among people, which will significantly influence the growth of the industry.

Browse Full Report @ https://www.reportsanddata.com/report-detail/hospital-acquired-infections-hai-diagnostics-market

Table of Content:

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Hospital Acquired Infections (HAI) Diagnostics Market Segmentation & Impact Analysis
4.1. Hospital Acquired Infections (HAI) Diagnostics Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Rise in geriatric population
4.2.2.2. Increase in resistance to antibiotics
4.2.3. Market restraints analysis
4.2.3.1. Fall in demand from emerging nations
4.3. Technological Insights
4.4. Regulatory Framework

Continued…

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3478

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370